Breaking News, Collaborations & Alliances

Cipla, Kemwell Biopharma, Manipal Form Cell Therapy JV

Aims to expedite development, manufacturing, licensing, import and export of cell therapy products.

Cipla entered into a strategic collaboration with Kemwell Biopharma and Manipal Education & Medical Group to incorporate a joint venture in the U.S. to develop and commercialize cell therapy products in the U.S., Japan, and EU. Cipla will secure a 35.2% stake in the joint venture company. Cipla will leverage its product development and commercialization with Kemwell’s expertise in biologics and Manipal’s expertise in healthcare delivery, to support development, manufacturing, ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters